Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Pig-to-human heart transplantation: A solution to the rarity of donor organs

Central University of Haryana Project Fellow Job Opening

Sun- Yellow ball of fire, Is it?

Pig-to-human heart transplantation: A solution to the rarity of donor organs
  • BiotechToday
  • World

Pig-to-human heart transplantation: A solution to the rarity of donor organs

bioxone October 10, 2020October 10, 2020

Sayak Banerjee, Amity University Kolkata

Many a time, a heart transplant is the only hope of survival for patients with any cardiac problems when every other surgery fails. For this, they have to wait for too long.

Cardiac xenotransplantation has been a target of scientists globally for years, and in one year, pig hearts might be transplanted to humans. A team of researchers from Massachusetts General Hospital (MGH) had published a recent analysis on the success of implanting pig hearts into baboons overcoming all the barriers through genetic engineering and drug development.

The team had elucidated that to prevent the immune system from attacking the pig hearts as “foreign”, genetically modified pigs were produced which were devoid of the carbohydrates that were the main target of the immune system. Moreover, to limit and control blood clots caused due to the incompatibility between human blood proteins and pig blood proteins, the pigs were engineered with a gene encoding for a human version of a protein, thrombomodulin.

Additionally, the researchers developed monoclonal antibodies that obstruct “costimulatory” molecules, CD40, and CD154 to inhibit the human immune cells from attacking the pig organs more convincingly than by immunosuppressants.

A question aroused that whether this transplant operation would impart some infectious diseases into humans or not. To this, one of the researchers had said that it was quite improbable because the culmination of the number of dedicated researches implemented by his team and others over the last few decades is such that it seems as pig-to-human heart transplantation is possible and could save many lives in the process.

He estimated that by the end of 2021, the first humans could receive pig hearts.

Source: https://doi.org/10.1161/CIRCULATIONAHA.120.048186

Also read: Mammalian ‘Third-Eye’: vertebrate retinal regeneration

For more latest updates visit bioxone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibody blood vessels cardiac problems cardiac surgery drug genetic engineering heart transplantation human blood proteins immune cells immune system immunosuppressants infectious diseases monoclonal antibodies Protein Surgery transplant transplantation xenotransplantation

6 thoughts on “Pig-to-human heart transplantation: A solution to the rarity of donor organs”

  1. Pingback: Underwater Archaeologists discover the oldest artifacts beneath Lake Huron - BioXone
  2. Pingback: Anaerobic gut fungi make way for novel antibiotic production - BioXone
  3. Pingback: Closteroviridae: An exceptional virus family in wild citrus plants - BioXone
  4. Pingback: A novel CNS-permeable reactivator counters nerve agent exposure - BioXone
  5. Pingback: A faster COVID diagnostic test with two CRISPR enzymes - BioXone
  6. Pingback: Microbial community fitness boost: Adaptive laboratory evolution - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Myth-Lysis

Sun- Yellow ball of fire, Is it?

bioxone October 10, 2020

Pratyushee Ghosh,  Amity University Kolkata Every child has held out for the yellow crayon or marker when it’s time to illustrate the sun. This common perception results in articles. Like one in Sciworthy, “The yellow sun in our sky provides the sunshine and energy needed to sustain our planet.” Pretty forgivable, on condition that even astronomers confer with the sun as a “yellow […]

Sun

Related Post

  • BiotechToday
  • World

Targeting viral protein ORF3a to fight Covid-19!

BioTech Today June 27, 2021June 27, 2021

Monika R, PSG College of Technology, Coimbatore The novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has caused a global pandemic of COVID-19 on an unprecedented scale. Coronaviruses may cause acute and chronic respiratory, enteric, and CNS infections. The presence of a large number of asymptomatic/mildly symptomatic patients, effective human-to-human transmission, and immunomodulatory characteristics of SARS-CoV-2 contribute […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Prognostic prediction score: A method to predict Pleuroparenchymal fibroelastosis

bioxone August 2, 2021August 2, 2021

Soumya Shraddhya Paul, Amity University, Noida Pleuroparenchymal fibroelastosis (PPFE) is an uncommon form of interstitial lung disease (ILD) that is characterised by elastofibrosis in the upper lobes. Patients with PPFE have several distinct clinical characteristics not seen in other ILDs. These are gradual weight loss and restrictive ventilatory dysfunction with increasing residual volume (RV). PPEE […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy